TLR4受体在肝癌细胞株HepG-2的表达(2)
 |
| 第1页 |
参见附件(1384KB，2页)。
本实验从基因的角度证明了肝癌细胞株HepG-2中有TLR4基因的转录，从蛋白的角度证实了肝癌细胞株HepG-2中有TLR4蛋白的表达，表明肝癌细胞株HepG-2有TLR4的表达。HepG-2细胞株是目前国际公认的肝癌细胞株，对于肝癌发生、发展、侵袭、转移甚至肝癌的治疗的许多研究都是利用HepG-2细胞株来完成的，本实验证明了肝癌细胞株表面有TLR4的表达，为今后对TLR4在肝癌中的作用及其作用途径的研究提供了实验对象，同时也未今后利用TLR4进行肿瘤治疗提供了实验对象。
[参考文献]
[1]Song PI, Abraham TA, Park Y,et al. The expression of functional LPS receptor proteins CD14 and Toll-like receptor 4 in human corneal cells[J]. Invest Ophthalmol Vis Sci，2001， 42: 2867-2877.
[2]Schmausser B, Andrulis M, Endrich S, et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori[J]. Int J Med Microbiol, 2005, 295(3): 179-185.
[3]Mozer-Lisewska I, Sluzewski W, Kaczmarek M, et al. Tissue localization of toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus[J]. Scandinavian Journal of Immunology, 2005, 62(4): 407-412.
[4]Takeda K, Kaisho T, Akira S. Toll-like receptors[J].Annu Rev Immunol, 2003, 21: 335-376.
[5]Huang B, Zhao J, Li H,et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance[J]. Cancer Res, 2005, 65(12): 5009-5014.
[6]金生,张大志,陈压西.Toll 样受体与肝脏疾病[J].中华内科杂志, 2005, 44(1): 68-69.
[7]Kaisho T, Akira S. Regulation of dendritic cell function through Toll-like receptors[J]. Curr Mol Med, 2003, 3: 373-385.
[8]Duesberg U, Vorr-dem-Bussche A, Kirsching C, et al. Cell activation by synthetic lipopeptides of the hepatitis C virus(HCV)-core protein is mediated by toll like receptors (TLRs) 2 and 4[J]. Immunol Lett, 2002, 84: 89-95.
(收稿日期：2008-02-27)
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(1384KB，2页)。